Palatin Technologies
PTN
$1.82
Share price
5.81%
Change (1 day)
-22.88%
Change (1 year)
Categories
Palatin Technologies (PTN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $24.93 M
According to Palatin Technologies's latest financial reports the company's total liabilities are $24.93 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-06-30 | $17.8 M | -10.09% |
| 2022-06-30 | $19.8 M | 12.23% |
| 2021-06-30 | $17.64 M | 261.52% |
| 2020-06-30 | $4.88 M | 16.6% |
| 2019-06-30 | $4.18 M | -65.27% |
| 2018-06-30 | $12.05 M | -80.56% |
| 2017-06-30 | $61.99 M | 117.96% |
| 2016-06-30 | $28.44 M | 64.7% |
| 2015-06-30 | $17.26 M | 523.41% |
| 2014-06-30 | $2.77 M | 32.18% |
| 2013-06-30 | $2.09 M | -40.96% |
| 2012-06-30 | $3.54 M | 19.07% |
| 2011-06-30 | $2.98 M | -2.92% |
| 2010-06-30 | $3.07 M | -68.94% |
| 2009-06-30 | $9.88 M | -21.37% |
| 2008-06-30 | $12.57 M | -48.15% |
| 2007-06-30 | $24.24 M | 11.5% |
| 2006-06-30 | $21.74 M | -16.17% |
| 2005-06-30 | $25.94 M | 208.32% |
| 2004-06-30 | $8.41 M | 107.01% |
| 2003-06-30 | $4.06 M | 10.71% |
| 2002-06-30 | $3.67 M | 57.67% |
| 2001-06-30 | $2.32 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 395,999.31% | 🇺🇸 USA |
 AstraZeneca AZN | $64.79 B | 259,699.83% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $1.01 B | 3,987.54% | 🇺🇸 USA |
 MediciNova MNOV | $3.89 M | -84.40% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $86.3 M | 246.05% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.44 B | 1,691.65% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $6.65 M | -73.32% | 🇺🇸 USA |
 Ardelyx ARDX | $0.13 B | 424.33% | 🇺🇸 USA |